Just as the United States was recording meaningful progress in reducing fentanyl overdose deaths, a combination of sweeping federal funding cuts and a militarised policy approach is threatening to reverse those gains, according to healthcare professionals and policy experts.
Progress Made, Then Disrupted
Starting in 2023, fentanyl overdose deaths fell nationwide for the first time in a decade — a milestone following a period in which overdose mortality rates doubled between 2015 and 2023. On the ground in Dallas, Texas, the Recovery Resource Council reported a drop in fentanyl-related deaths in Dallas County from 280 in 2023 to 203 last year, crediting grassroots outreach efforts such as doorstep visits made within 72 hours of a reported overdose.
However, recent data suggests the number of overall overdose deaths is once again rising, with experts warning that a disruption in the fentanyl supply chain has been resolved and the market has largely shifted its chemical sourcing from China to India.
Funding Cuts Undermine Treatment Network
The administration of President Donald Trump has cut hundreds of millions of dollars from addiction services and drug-related research across multiple federal agencies. Elon Musk's DOGE initiative disbanded a team that had tracked Americans' drug use for decades. In January, roughly $2 billion in grants through the Substance Abuse and Mental Health Services Administration (SAMHSA) were abruptly cancelled before being partially reinstated — leaving service providers in a state of prolonged uncertainty. SAMHSA's staffing levels have since been reduced by approximately half.
Reporting by health news outlet STAT indicated that at least $1.7 billion in block grants to state health departments had been cut, along with around $350 million in addiction and overdose prevention funding.
The Big Cities Health Coalition, which represents health departments in major US cities, warns the consequences extend far beyond government agencies themselves.
"It's not just the health department that can't do something. It's not just the health department that's forced to lay off staff. It's all of the other pieces that come together in these jurisdictions where there's partnerships," said Chrissie Julianno, the coalition's executive director.
Military Framing Draws Expert Criticism
Despite labelling fentanyl a "weapon of mass destruction", the Trump administration has drawn criticism for pursuing military actions — including boat strikes against Venezuela — as part of its anti-fentanyl strategy, even though Venezuela is not a source of the drug.
Jonathan Caulkins, a drugs and violence researcher at Carnegie Mellon University, cautioned against repurposing terms with precise meanings for political effect.
"By those arguments, cigarettes would be weapons of mass destruction — cigarettes kill more Americans every year than fentanyl does," Caulkins told STAT.
Others expressed concern that inflammatory language further stigmatises addiction and discourages people from seeking help. A Dallas woman who has struggled with opioid addiction, speaking under a pseudonym due to pending legal proceedings, questioned what the framing communicates to those still in the grip of addiction.
What Experts Say Is Needed
Ben Westhoff, author of Fentanyl, Inc, acknowledges that law enforcement and military measures play a role in disrupting drug supply chains — particularly in countries where fentanyl originates. However, he argues that sustained investment in healthcare and community-level services is equally essential.
For outreach workers like Michael Watkins of the Recovery Resource Council — himself a recovering addict of 13 years — the path forward is rooted in human connection and accessible services. A planned addiction resource team for Plano, one of Dallas's largest suburbs, was placed on hold due to federal funding cuts, illustrating the direct local impact of national policy decisions.
Experts broadly agree that without restoring and expanding community-based treatment infrastructure, the progress achieved since 2023 remains fragile and reversible.
